Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02245048 · ClinicalTrials.gov registry record
CIMT and Plaque Assessment Findings in Subjects Undergoing Stress Echocardiography For Risk Stratification
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 73
- Enrollment target
NCT02245048: Completed study, sponsored by Mayo Clinic.
NCT02245048 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02245048 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if carotid artery ultrasound scanning can provide additional information for determining cardiovascular risk in patients. Patients who agree to participate wil undergo non-invasive carotid intima-media thickness (CIMT) measurement and plaque assessment. Findings of CIMT will be compared to results of patient standard of care stress echocardiogram (SE) and of diastolic function. We hypothesize tht 1) in patients undergoing SE for inappropriate or uncertain indications, CIMT and plaque assessment will provide useful risk stratification beyond use of traditional risk factors; 2) CIMT findings will correlate with results of SE in terms of exercise capacity and 3) Exercise capacity will correlate with diastolic function.
Interventions
- OTHER Carotid Intima-Media Thickness (CIMT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02245048
The ClinicalTrials.gov registry entry for NCT02245048 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carotid Intima-Media Thickness (CIMT) is the first listed.
NCT02245048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02245048 about?
NCT02245048 is a clinical study titled "CIMT and Plaque Assessment Findings in Subjects Undergoing Stress Echocardiography For Risk Stratification". The purpose of this research study is to determine if carotid artery ultrasound scanning can provide additional information for determining cardiovascular risk in patients. Patients who agree to participate wil undergo non-invasive carotid intima-media thickness (CIMT) measurement and plaque assess...
What is the current status of trial NCT02245048?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2014-10. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02245048?
The interventions under investigation include: Carotid Intima-Media Thickness (CIMT) (OTHER).
Who is sponsoring clinical trial NCT02245048?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.